Sort
16,179 grants matching “malaria”
Epidemiology, Prevention, and Treatment of Influenza and Other Respiratory Infect
$1,210,000Dean Barry Everett · University Of Liverpool · U01 · FY2016 · IP
Arthropod saliva in vector-borne disease transmission: Functional analysis of novel domains in salivary secretions
$1,207,928Eric Calvo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Long-term health and socioeconomic impact of interventions targeting low-density malaria infection (LMI) among children in Tanzania
$1,206,533Michelle Sang Hsiang · University Of California, San Francisco · U01 · FY2023 · AI
East Africa IEDEA Regional Consortium
$1,206,226Constantin T Yiannoutsos · Indiana University Indianapolis · U01 · FY2010 · AI
Once Bitten: Acquisition of Malaria Adaptive Immunity (OBAMA - Immunity)
$1,206,058Wendy Prudhommeomeara · Duke University · R01 · FY2024 · AI
Malaria Pathogenesis and Human Immunity
$1,205,828Rick Fairhurst · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Research Resources: Epigenomic and Transcriptomic Profiles of Human Immune Cells
$1,205,532Anjana Rao · La Jolla Institute For Immunology · R24 · FY2015 · AI
Malaria Pathogenesis in Pregnant Women and Young Children
$1,205,169Michal Fried · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Biologically informed design of CD8+ T cell-dependent pre-erythrocytic stage malaria vaccines
$1,204,933Stefan H.i. Kappe · Seattle Children'S Hospital · U01 · FY2025 · AI
DIALS: supporting structural biology through open source diffraction processing software
$1,204,713Aaron Samuel Brewster · University Of Calif-Lawrenc Berkeley Lab · R24 · FY2024 · GM
Research Resources: Epigenomic and Transcriptomic Profiles of Human Immune Cells
$1,204,371Anjana Rao · La Jolla Institute For Immunology · R24 · FY2016 · AI
Host-parasite-vector interactions during malaria transmission
$1,202,210Joel Vega-Rodriguez · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
DON in Pediatric Cerebral Malaria: A Phase I / II Dose-Escalation Safety Study
$1,201,442Douglas Postels · Children'S Research Institute · U01 · FY2023 · AI
Clinical trial of chloroquine weekly or as IPT to prevent malaria in pregnancy in
$1,200,349Miriam K Laufer · University Of Maryland Baltimore · U01 · FY2013 · AI
Epidemiology, Prevention, and Treatment of Influenza and Other Respiratory Infect
$1,200,000Dean Barry Everett · University Of Liverpool · U01 · FY2015 · IP
Collaborative Research: Microparasite-Macroparasite Interactions: Dynamics of Co-infection and Implications for Disease Control
$1,198,658Anna E Jolles · Oregon State University · · FY2007 · BIO
Optimal chemopreventive regimens to prevent malaria and improve birth outcomes in Uganda
$1,197,862Matthew G Dorsey · University Of California, San Francisco · U01 · FY2021 · AI
The Intransigence of Malaria in Malawi: Understanding Hidden Reservoirs, Successful Vectors and Prevention Failures
$1,195,625Terrie Ellen Taylor · Michigan State University · U19 · FY2017 · AI
Genetic and Environmental Modifiers Of Autoimmune Disease
$1,195,579Silvia Bolland · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Optimal chemopreventive regimens to prevent malaria and improve birth outcomes in Uganda
$1,194,675Matthew G Dorsey · University Of California, San Francisco · U01 · FY2020 · AI
DON in Pediatric Cerebral Malaria: A Phase I / II Dose-Escalation Safety Study
$1,194,173Douglas Postels · Children'S Research Institute · U01 · FY2022 · AI
The Intransigence of Malaria in Malawi: Understanding Hidden Reservoirs, Successful Vectors and Prevention Failures
$1,191,008Terrie Ellen Taylor · Michigan State University · U19 · FY2018 · AI
Validation of New Antimalarial Leads
$1,190,932Jeremy Nicholas Burrows · Medicines For Malaria Venture · R01 · FY2014 · AI
Validation of New Antimalarial Leads
$1,190,932James Duffy · Medicines For Malaria Venture · R01 · FY2015 · AI
Validation of New Antimalarial Leads
$1,190,932David Waterson · Medicines For Malaria Venture · R01 · FY2012 · AI